Gallifen 40 mg/g premix for medicated feeding stuff for chickens and pheasants
Gallifen 40 mg/g premix for medicated feeding stuff for chickens and pheasants
Authorised
- Fenbendazole
Product identification
Medicine name:
Gallifen 40 mg/g premix for medicated feeding stuff for chickens and pheasants
Gallifen 40 mg/g Premix voor gemedicineerd voer
Gallifen 40 mg/g Prémélange médicamenteux
Gallifen 40 mg/g Arzneimittel-Vormischung zur Herstellung von Fütterungsarzneimitteln
Active substance:
- Fenbendazole
Target species:
-
Chicken
-
Pheasant
Route of administration:
-
In-feed use
Product details
Active substance and strength:
-
Fenbendazole40.00/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Premix for medicated feeding stuff
Withdrawal period by route of administration:
-
In-feed use
-
Chicken
-
Eggs0day
-
Meat and offal8day
-
-
Pheasant
-
Eggs0day
-
Meat and offal8dayDo not release pheasants for hunting for at least 8 days after the end of medication
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AC13
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- Polyethylene/aluminium foil/polyethylene terephthalate zipper bags of 5 kg.
- Polyethylene/aluminium foil/polyethylene terephthalate zipper bags of 2 kg.
- Polyethylene/aluminium foil/polyethylene terephthalate zipper bags of 1 kg.
- Polyethylene-aluminium-paper /paper/paper bag of 20 kg.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
- Biovet AD
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0555/001
Concerned member states:
-
Belgium
-
Bulgaria
-
France
-
Hungary
-
Italy
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Labelling
This document does not exist in this language (English). You can find it
in another language below.